Synovial Fluid Biomarkers in Knee Injury and Osteoarthritis

Synovial fluid, the viscous medium that bathes articular cartilage, offers a direct window into the molecular events underlying knee injury and osteoarthritis. Biomarkers present in this fluid encompass a range of molecules—cytokines, chemokines, matrix fragments, lipid mediators and growth factors—that reflect acute tissue damage, inflammatory activation and cartilage turnover. In the setting of acute trauma, early rises in interleukin-6 and matrix metalloproteinases mirror tissue stress responses, whereas later elevations in collagen telopeptides signal irreversible matrix breakdown. In chronic osteoarthritis, distinct profiles of aggrecan neoepitope fragments and pro-inflammatory mediators correlate with radiographic progression and symptom severity. Advances in multiplex immunoassays, mass spectrometry and next-generation sequencing have enabled simultaneous quantification of dozens of molecules, facilitating the identification of biomarker panels that stratify patients by risk, guide therapeutic timing and monitor response. The integration of synovial fluid biomarker profiles with imaging and clinical scores holds promise for early diagnosis, personalised treatment and the development of targeted disease-modifying agents.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Synovial Fluid Biomarkers in Knee Injury and Osteoarthritis publication trend

The graph below shows the total number of articles in synovial fluid biomarkers in knee injury and osteoarthritis across all publications each year (not limited to Nature Index journals).

Technical terms

Synovial fluid: The lubricating and nutritive fluid that fills joint cavities, used for biomarker assessment.

Biomarker: A measurable molecule indicating normal or pathogenic processes, or pharmacological responses.

Cytokine: A small signalling protein, such as interleukins, that modulates immune and inflammatory responses.

Matrix metalloproteinase (MMP): An enzyme family that degrades extracellular matrix components during tissue remodelling.

Aggrecan ARGS fragments: Neoepitope peptides released by aggrecanase cleavage at the Glu-Ala bond in cartilage proteoglycan.

Interleukin-6 (IL-6): A multifunctional cytokine implicated in acute inflammation, cartilage catabolism and pain signalling.

Synovitis: Inflammation of the synovial membrane characterized by cellular infiltration and increased fluid volume.

References

1. Acute Molecular Changes in Synovial Fluid Following Human Knee Injury: Association With Early Clinical Outcomes. Arthritis & Rheumatology (2016).
2. Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study. Arthritis Research & Therapy (2009).
3. Association between synovial fluid levels of aggrecan ARGS fragments and radiographic progression in knee osteoarthritis. Arthritis Research & Therapy (2010).
4. Molecular changes indicative of cartilage degeneration and osteoarthritis development in patients with anterior cruciate ligament injury. BMC Musculoskeletal Disorders (2016).
5. Immune cell profiles in synovial fluid after anterior cruciate ligament and meniscus injuries. Arthritis Research & Therapy (2021).